nach oben

Journal of Neuro-Oncology

Erschienen in:

01.01.2009 | Laboratory Investigation- Human/Animal Tissue

Zhangfei induces the expression of the nerve growth factor receptor, trkA, in medulloblastoma cells and causes their differentiation or apoptosis

verfasst von: Ximena Valderrama, Noreen Rapin, Valerie M. K. Verge, Vikram Misra

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Interactions between nerve growth factor (NGF) and its receptor—the tropomyosin related kinase A (trkA)—regulate many neuronal functions including the correct development of sensory neurons during embryogenesis, the survival of sensory neurons and the differentiation and apoptosis of neuronal tumours. Zhangfei is a transcriptional factor that is expressed in differentiated neurons. Since we could detect Zhangfei in mature neurons but not in neuronal tumour cells, we hypothesised that ectopic expression of the protein in medulloblastoma cells may induce the differentiation of these cells. We show that in ONS-76 medulloblastoma cells, resveratrol, an inducer of apoptosis and differentiation, increased the expression of Zhangfei, trkA and Early Growth Response Gene 1 (Egr1), a gene normally activated by NGF–trkA signalling. ONS-76 cells stopped growing soon after treatment with resveratrol. While the induction of Zhangfei in resveratrol-treated cells was modest albeit consistent, the infection of actively growing medulloblastoma cells with an adenovirus vector expressing Zhangfei mimicked some of the effects of resveratrol. Ectopically expressed Zhangfei in ONS-76 cells led to the increased expression of trkA and Egr1, phosphorylation of extracellular signal-regulated kinase (Erk1), and caused ONS-76 cells to display markers of apoptosis. UW228, another medulloblastoma cell-line, was also susceptible to the suppressive effects of resveratrol and Zhangfei. In contrast, while resveratrol suppressed the growth of human diploid fibroblasts (MRC5), Zhangfei had relatively little effect on these cells.

Parada LF, Tsoulfas P, Tessarollo L, Blair J, Reid SW, Soppet D (1992) The Trk family of tyrosine kinases: receptors for NGF-related neurotrophins. Cold Spring Harb Symp Quant Biol 57:43–51PubMed

Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609–642. doi:10.1146/annurev.biochem.72.121801.161629 PubMedCrossRef

Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP et al (1994) Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76:1001–1011. doi:10.1016/0092-8674(94)90378-6 PubMedCrossRef

Martin-Zanca D, Barbacid M, Parada LF (1990) Expression of the trk proto-oncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development. Genes Dev 4:683–694. doi:10.1101/gad.4.5.683 PubMedCrossRef

Bibel M, Barde YA (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14:2919–2937. doi:10.1101/gad.841400 PubMedCrossRef

Verge VM, Merlio JP, Grondin J, Ernfors P, Persson H, Riopelle RJ et al (1992) Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J Neurosci 12:4011–4022PubMed

Verge VM, Richardson PM, Wiesenfeld-Hallin Z, Hokfelt T (1995) Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. J Neurosci 15:2081–2096PubMed

Sasaki K, Chancellor MB, Goins WF, Phelan MW, Glorioso JC, de Groat WC et al (2004) Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 53:2723–2730. doi:10.2337/diabetes.53.10.2723 PubMedCrossRef

Walwyn WM, Matsuka Y, Arai D, Bloom DC, Lam H, Tran C et al (2006) HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy. Exp Neurol 198:260–270. doi:10.1016/j.expneurol.2005.12.006 PubMedCrossRef

10.

Kriesel JD (1999) Reactivation of herpes simplex virus: the role of cytokines and intracellular factors. Curr Opin Infect Dis 12:235–238PubMed

11.

Hill JM, Garza HHJ, Helmy MF, Cook SD, Osborne PA, Johnson EMJ et al (1997) Nerve growth factor antibody stimulates reactivation of ocular herpes simplex virus type 1 in latently infected rabbits. J Neurovirol 3:206–211PubMedCrossRef

12.

Laycock KA, Brady RH, Lee SF, Osborne PA, Johnson EM, Pepose JS (1994) The role of nerve growth factor in modulating herpes simplex virus reactivation in vivo. Graefes Arch Clin Exp Ophthalmol 232:421–425. doi:10.1007/BF00186584 PubMedCrossRef

13.

Wilcox CL, Smith RL, Freed CR, Johnson EMJ (1990) Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci 10:1268–1275PubMed

14.

Antonelli A, Lenzi L, Nakagawara A, Osaki T, Chiaretti A, Aloe L (2007) Tumor suppressor proteins are differentially affected in human ependymoblastoma and medulloblastoma cells exposed to nerve growth factor. Cancer Invest 25:94–101. doi:10.1080/07357900701205689 PubMedCrossRef

15.

Eberhart CG, Kaufman WE, Tihan T, Burger PC (2001) Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules. J Neuropathol Exp Neurol 60:462–469PubMed

16.

Ohta T, Watanabe T, Katayama Y, Kurihara J, Yoshino A, Nishimoto H et al (2006) TrkA expression is associated with an elevated level of apoptosis in classic medulloblastomas. Neuropathology 26:170–177. doi:10.1111/j.1440-1789.2006.00678.x PubMedCrossRef

17.

Tajima Y, Molina RP Jr, Rorke LB, Kaplan DR, Radeke M, Feinstein SC et al (1998) Neurotrophins and neuronal versus glial differentiation in medulloblastomas and other pediatric brain tumors. Acta Neuropathol 95:325–332. doi:10.1007/s004010050806 PubMedCrossRef

18.

Chou TT, Trojanowski JQ, Lee VM (2000) A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma. J Biol Chem 275:565–570. doi:10.1074/jbc.275.1.565 PubMedCrossRef

19.

Eggert A, Ikegaki N, Liu X, Chou TT, Lee VM, Trojanowski JQ et al (2000) Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 19:2043–2051. doi:10.1038/sj.onc.1203518 PubMedCrossRef

20.

Muragaki Y, Chou TT, Kaplan DR, Trojanowski JQ, Lee VM (1997) Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors. J Neurosci 17:530–542PubMed

21.

Efstathiou S, Preston CM (2005) Towards an understanding of the molecular basis of herpes simplex virus latency. Virus Res 111:108–119. doi:10.1016/j.virusres.2005.04.017 PubMedCrossRef

22.

Roizman B, Knipe DM (2001) Herpes simplex viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE (eds) Fields virology. Lippincott Willaims and Wilkins, Philadelphia, PA, pp 2399–2460

23.

Wilcox C, Johnson E (1987) Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol 61:2311–2315PubMed

24.

Wilcox C, Johnson E (1988) Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J Virol 62:393–399PubMed

25.

Wysocka J, Herr W (2003) The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem Sci 28:294–304. doi:10.1016/S0968-0004(03)00088-4 PubMedCrossRef

26.

Julien E, Herr W (2003) Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF-1. EMBO J 22:2360–2369. doi:10.1093/emboj/cdg242 PubMedCrossRef

27.

Ajuh P, Chusainow J, Ryder U, Lamond AI (2002) A novel function for human factor C1 (HCF-1), a host protein required for herpes simplex virus infection, in pre-mRNA splicing. EMBO J 21:6590–6602. doi:10.1093/emboj/cdf652 PubMedCrossRef

28.

Wysocka J, Myers MP, Laherty CD, Eisenman RN, Herr W (2003) Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev 17:896–911. doi:10.1101/gad.252103 PubMedCrossRef

29.

Narayanan A, Nogueira ML, Ruyechan WT, Kristie TM (2005) Combinatorial transcription of herpes simplex virus and varicella zoster virus immediate early genes is strictly determined by the cellular coactivator HCF-1. J Biol Chem 280:1369–1375. doi:10.1074/jbc.M410178200 PubMedCrossRef

30.

Hughes TA, La Boissiere S, O’Hare P (1999) Analysis of functional domains of the host cell factor involved in VP16 complex formation. J Biol Chem 274:16437–16443. doi:10.1074/jbc.274.23.16437 PubMedCrossRef

31.

Wilson AC, Freiman RN, Goto H, Nishimoto T, Herr W (1997) VP16 targets an amino-terminal domain of HCF involved in cell cycle progression. Mol Cell Biol 17:6139–6146PubMed

32.

Narayanan A, Ruyechan WT, Kristie TM (2007) The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection. Proc Natl Acad Sci USA 104:10835–10840. doi:10.1073/pnas.0704351104 PubMedCrossRef

33.

Tyagi S, Chabes AL, Wysocka J, Herr W (2007) E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol Cell 27:107–119. doi:10.1016/j.molcel.2007.05.030 PubMedCrossRef

34.

Knez J, Piluso D, Bilan P, Capone JP (2006) Host cell factor-1 and E2F4 interact via multiple determinants in each protein. Mol Cell Biochem 288:79–90. doi:10.1007/s11010-006-9122-x PubMedCrossRef

35.

Luciano RL, Wilson AC (2003) HCF-1 functions as a coactivator for the zinc finger protein Krox20. J Biol Chem 278:51116–51124. doi:10.1074/jbc.M303470200 PubMedCrossRef

36.

Lu R, Misra V (2000) Potential role for Luman, the cellular homologue of herpes simplex virus VP16 (alpha gene trans-inducing factor), in herpesvirus latency. J Virol 74:934–943. doi:10.1128/JVI.74.2.934-943.2000 PubMedCrossRef

37.

Lu R, Yang P, O’Hare P, Misra V (1997) Luman, a new member of the CREB/ATF family, binds to herpes simplex virus VP16-associated host cellular factor. Mol Cell Biol 17:5117–5126PubMed

38.

Lu R, Yang P, Padmakumar S, Misra V (1998) The herpesvirus transactivator VP16 mimics a human basic domain leucine zipper protein, Luman, in its interaction with HCF. J Virol 72:6291–6297PubMed

39.

Lu R, Misra V (2000) Zhangfei: a second cellular protein interacts with herpes simplex virus accessory factor HCF in a manner similar to Luman and VP16. Nucleic Acids Res 28:2446–2454. doi:10.1093/nar/28.12.2446 PubMedCrossRef

40.

Hogan MR, Cockram GP, Lu R (2006) Cooperative interaction of Zhangfei and ATF4 in transactivation of the cyclic AMP response element. FEBS Lett 580:58–62. doi:10.1016/j.febslet.2005.11.046 PubMedCrossRef

41.

Misra V, Rapin N, Akhova O, Bainbridge M, Korchinski P (2005) Zhangfei is a potent and specific inhibitor of the host cell factor-binding transcription factor Luman. J Biol Chem 280:15257–15266. doi:10.1074/jbc.M500728200 PubMedCrossRef

42.

Akhova O, Bainbridge M, Misra V (2005) The neuronal host cell factor-binding protein Zhangfei inhibits herpes simplex virus replication. J Virol 79:14708–14718. doi:10.1128/JVI.79.23.14708-14718.2005 PubMedCrossRef

43.

Newman JR, Keating AE (2003) Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 300:2097–2101. doi:10.1126/science.1084648 PubMedCrossRef

44.

Yamada M, Shimizu K, Tamura K, Okamoto Y, Matsui Y, Moriuchi S et al (1989) Establishment and biological characterization of human medulloblastoma cell lines. No To Shinkei 41:695–702

45.

Keles GE, Berger MS, Srinivasan J, Kolstoe DD, Bobola MS, Silber JR (1995) Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol Res 7:493–503PubMed

46.

Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W et al (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402. doi:10.1093/nar/25.17.3389 PubMedCrossRef

47.

Chen Y, Tseng SH, Lai HS, Chen WJ (2004) Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 136:57–66. doi:10.1016/j.surg.2004.01.017 PubMedCrossRef

48.

Nicolini G, Rigolio R, Scuteri A, Miloso M, Saccomanno D, Cavaletti G et al (2003) Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int 42:419–429. doi:10.1016/S0197-0186(02)00132-8 PubMedCrossRef

49.

Tredici G, Miloso M, Nicolini G, Galbiati S, Cavaletti G, Bertelli A (1999) Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant? Drugs Exp Clin Res 25:99–103PubMed

50.

Wang Q, Li H, Wang XW, Wu DC, Chen XY, Liu J (2003) Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells. Neurosci Lett 351:83–86. doi:10.1016/j.neulet.2003.07.002 PubMedCrossRef

51.

Zhang P, Li H, Wu ML, Chen XY, Kong QY, Wang XW et al (2006) c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells. J Neurooncol 80:123–131. doi:10.1007/s11060-006-9172-7 PubMedCrossRef

52.

Park KC, Shimizu K, Hayakawa T (1998) Interferon yield and MHC antigen expression of human medulloblastoma cells and its suppression during dibutyryl cyclic AMP-induced differentiation: do medulloblastoma cells derive from bipotent neuronal and glial progenitors? Cell Mol Neurobiol 18:497–507. doi:10.1023/A:1026327309345 PubMedCrossRef

53.

Harada T, Morooka T, Ogawa S, Nishida E (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol 3:453–459. doi:10.1038/35074516 PubMedCrossRef

54.

Jacobs JP, Jones CM, Baille JP (1970) Characteristics of a human diploid cell designated MRC-5. Nature 227:168–170. doi:10.1038/227168a0 PubMedCrossRef

55.

Wechsler-Reya RJ (2003) Analysis of gene expression in the normal and malignant cerebellum. Recent Prog Horm Res 58:227–248. doi:10.1210/rp.58.1.227 PubMedCrossRef

56.

Wechsler-Reya RJ, Scott MP (1999) Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22:103–114. doi:10.1016/S0896-6273(00)80682-0 PubMedCrossRef

57.

Fogarty MP, Emmenegger BA, Grasfeder LL, Oliver TG, Wechsler-Reya RJ (2007) Fibroblast growth factor blocks Sonic hedgehog signaling in neuronal precursors and tumor cells. Proc Natl Acad Sci USA 104:2973–2978. doi:10.1073/pnas.0605770104 PubMedCrossRef

58.

Kokunai T, Sawa H, Tamaki N (1996) Functional analysis of trk proto-oncogene product in medulloblastoma cells. Neurol Med Chir (Tokyo) 36:796–804. doi:10.2176/nmc.36.796 CrossRef

59.

Keles GE, Berger MS, Schofield D, Bothwell M (1993) Nerve growth factor receptor expression in medulloblastomas and the potential role of nerve growth factor as a differentiating agent in medulloblastoma cell lines. Neurosurgery 32:274–280 (discussion 280)PubMedCrossRef

60.

Izumiya Y, Lin SF, Ellison T, Chen LY, Izumiya C, Luciw P et al (2003) Kaposi’s sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J Virol 77:1441–1451. doi:10.1128/JVI.77.2.1441-1451.2003 PubMedCrossRef

61.

Park J, Seo T, Hwang S, Lee D, Gwack Y, Choe J (2000) The K-bZIP protein from Kaposi’s sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J Virol 74:11977–11982. doi:10.1128/JVI.74.24.11977-11982.2000 PubMedCrossRef

62.

Lefort S, Soucy-Faulkner A, Grandvaux N, Flamand L (2007) Binding of Kaposi’s sarcoma-associated herpesvirus K-bZIP to interferon responsive factor 3 elements modulates antiviral genes expression. J Virol 81:10950–10960. doi:10.1128/JVI.00183-07 PubMedCrossRef

63.

Wu FY, Wang SE, Tang QQ, Fujimuro M, Chiou CJ, Zheng Q et al (2003) Cell cycle arrest by Kaposi’s sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1). J Virol 77:8893–8914. doi:10.1128/JVI.77.16.8893-8914.2003 PubMedCrossRef

64.

Miloso M, Bertelli AA, Nicolini G, Tredici G (1999) Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. Neurosci Lett 264:141–144. doi:10.1016/S0304-3940(99)00194-9 PubMedCrossRef

65.

Serra JM, Gutierrez A, Alemany R, Navarro M, Ros T, Saus C et al (2008) Inhibition of c-Myc down-regulation by sustained ERK activation prevents the antimetabolite methotrexate- and gemcitabine-induced differentiation in non-small cell lung cancer cells. Mol Pharmacol 73:1679–1687. doi:10.1124/mol.107.043372 CrossRef

Titel: Zhangfei induces the expression of the nerve growth factor receptor, trkA, in medulloblastoma cells and causes their differentiation or apoptosis
verfasst von: Ximena Valderrama
Noreen Rapin
Valerie M. K. Verge
Vikram Misra
Publikationsdatum: 01.01.2009
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 1/2009
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-008-9682-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Isolated sphenoid sinusitis or mucocele: a potential complication of endonasal transsphenoidal surgery

A de novo desmoid tumor of the surgical site following foramen magnum meningioma resection in a patient with Gardner’s Syndrome: a case report and review of the literature

Surgical resection and permanent iodine-125 brachytherapy for brain metastases

End of life issues in brain tumor patients

Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component